Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of Telmisartan, Amlodipine and Hydrochlorothiazide
NCT03889145Phase 1Completed
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- Dec 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of telmisartan + amlodipine + hydrochlorothiazide in hypertension (HTN) (3 arms), sponsored by Ildong Pharmaceutical Co Ltd. Primary endpoints: Area Under the Curve to the last measurable concentration at 144 hours and Maximum Plasma Concentration at 144 hours. Started Dec 2013; status: completed.
02
Drugs
telmisartan + amlodipine + hydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03889145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03889145.